x
Filter:
Filters applied
- DNA and Chromosomes
- Gu, LiyaRemove Gu, Liya filter
- mismatch repairRemove mismatch repair filter
Publication Date
Please choose a date range between 2021 and 2022.
Keyword
- MMR2
- ChIP-Seq1
- chromatin immunoprecipitation assays combined with DNA sequencing1
- CHX1
- Co-IP1
- coimmunoprecipitation1
- cycloheximide1
- DDR1
- deubiquitination1
- DNA damage1
- DNA damage response1
- DNA mismatch repair1
- FACS1
- fluorescence-activated cell sorting1
- histone methylation1
- KD1
- KI1
- MNNG1
- N-methyl-N'-nitro-N-nitrosoguanidine1
- OTUB11
- RIPA1
- ROS1
- SETD21
- TSS1
DNA and Chromosomes
2 Results
- Research ArticleOpen Access
Interplay between H3K36me3, methyltransferase SETD2, and mismatch recognition protein MutSα facilitates processing of oxidative DNA damage in human cells
Journal of Biological ChemistryVol. 298Issue 7102102Published online: June 3, 2022- Sida Guo
- Jun Fang
- Weizhi Xu
- Janice Ortega
- Chang-Yi Liu
- Liya Gu
- and others
Cited in Scopus: 0Oxidative DNA damage contributes to aging and the pathogenesis of numerous human diseases including cancer. 8-hydroxyguanine (8-oxoG) is the major product of oxidative DNA lesions. Although OGG1-mediated base excision repair is the primary mechanism for 8-oxoG removal, DNA mismatch repair has also been implicated in processing oxidative DNA damage. However, the mechanism of the latter is not fully understood. Here, we treated human cells defective in various 8-oxoG repair factors with H2O2 and performed biochemical, live cell imaging, and chromatin immunoprecipitation sequencing analyses to determine their response to the treatment. - Research ArticleOpen Access
OTUB1 stabilizes mismatch repair protein MSH2 by blocking ubiquitination
Journal of Biological ChemistryVol. 296100466Published online: February 25, 2021- Qiong Wu
- Yaping Huang
- Liya Gu
- Zhijie Chang
- Guo-Min Li
Cited in Scopus: 7DNA mismatch repair (MMR) maintains genome stability primarily by correcting replication errors. MMR deficiency can lead to cancer development and bolsters cancer cell resistance to chemotherapy. However, recent studies have shown that checkpoint blockade therapy is effective in MMR-deficient cancers, thus the ability to identify cancer etiology would greatly benefit cancer treatment. MutS homolog 2 (MSH2) is an obligate subunit of mismatch recognition proteins MutSα (MSH2-MSH6) and MutSβ (MSH2-MSH3).